| Category: | Health, |
|---|---|
| Address: | 4820 Seton Dr # C, Baltimore, MD 21215, USA |
| Postal code: | 21215 |
| Phone: | (410) 358-6886 |
| Website: | http://www.cel-sci.com/ |
| Monday: | 8:00 AM – 5:00 PM |
|---|---|
| Tuesday: | 8:00 AM – 5:00 PM |
| Wednesday: | 8:00 AM – 5:00 PM |
| Thursday: | 8:00 AM – 5:00 PM |
| Friday: | 8:00 AM – 5:00 PM |
| Saturday: | Closed |
| Sunday: | Closed |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Cel-Sci Corporation, use the form below and your opinion, advice or comment will appear in this space.
CEL-SCI Corporation. Dedicated to research and development directed at improving the treatment of cancer, autoimmune and infectious diseases. CEL-SCI is a pioneer in cancer immunotherapy. Our Phase III clinical trial in head and neck cancer tests the idea that we should boost the immune system...
Cel-Sci Corporation. 449 likes · 29 talking about this · 2 were here. CEL-SCI CEO Geert Kersten recently spoke to @SNNInvestorNetwork via Zoom to provide Company updates and engage in a discussion relating to our Phase 3 Head and Neck Cancer Study.
Последние твиты от CEL-SCI Corporation (@CelSciCorp). CEL-SCI's official Twitter handle. We are an immunotherapy company that focuses on unmet medical needs in oncology and infectious diseases.
Find the latest Cel-Sci Corporation (CVM) stock quote, history, news and other vital information to help you with your stock trading and investing. CEL-SCI Corporation (CVM). NYSE American - NYSE American Delayed Price. Currency in USD.
Cel-Sci Corporation (NYSE American: CVM), is a biotechnology company that is testing drugs for the treatment of cancer, autoimmune and infectious diseases through the research and development of...
CEL-SCI (CVM -5.4%) is down on average volume on the heels of a letter to shareholders from CEO Geert Kersten detailing its rationale for Multikine for the. CEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the...
Cel-Sci Corporation. 8229 Boone Boulevard, Suite 802, Vienna (VA), 22182, United States. CEL-SCI is dedicated to research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system.
CEL-SCI Corporation is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. * CEL-SCI CORPORATION RECEIVES $10 MILLION THROUGH WARRANT EXERCISES Source text for Eikon: Further company coverage
Cel-Sci Corporation, also called CEL-SCI, is a biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope...
CEL-SCI Corporation (NYSE:CVM) today announced that the European Patent Office has issued CEL-SCI patent: European Patent 2989121 to be published on October 7, 2020, and titled "Method of Preparation and Composition of Peptide Constructs for Treatment of Rheumatoid Arthritis" for the...